Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
65.00    -2.50 (-3.70%)
Bid:
66.50
Ask:
68.00
Spread: 1.50 (2.256%)
Market Cap: £101.06m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Extension of Share Buyback Programme

12 May 2026 15:30

RNS Number : 0338E
Macfarlane Group PLC
12 May 2026
 

12 May 2026

Macfarlane Group PLC

("Macfarlane", the "Company", or the "Group")

Extension of share buyback programme

Macfarlane Group PLC announces an extension to the long stop expiry date of its existing share buyback programme (the "Programme").

On 25 May 2025, the Company announced the launch of the Programme for up to a maximum amount of £4 million. Since the commencement of the Programme, the Company has repurchased 3,424,509 ordinary shares of 25 pence each (the "Ordinary Shares") in aggregate for total consideration of approximately £2.8 million. Accordingly, approximately £1.2 million remains to be deployed under the Programme. In order to allow the existing Programme to continue to completion, the Board has resolved to extend the long stop expiry date for the Programme from 29 May 2026 until the earlier of: (i) the Programme having reached its £4 million maximum amount, or (ii) close of business on 31 December 2026, unless the Company and Shore Capital Stockbrokers Limited agree otherwise (in which event an announcement would be made).

The Company has instructed Shore Capital Stockbrokers Limited to conduct the remainder of the Programme on the Company's behalf on an irrevocable and non-discretionary basis. The Programme will continue to be effected within pre-set parameters, including that the maximum price paid per Ordinary Share shall be no more than 105 per cent. of the trailing five-day average mid-market price, and in accordance with and under the terms of the general authority granted to the Board by the Company's shareholders at the Company's annual general meeting on 12 May 2026 (the "General Authority"). Ordinary Shares acquired under the Programme will continue to be cancelled which will reduce the share capital of the Company.

Any purchases of Ordinary Shares by the Company in relation to the Programme will continue to be conducted in accordance with the General Authority and, insofar as is possible, in accordance with the safe harbour parameters of the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by virtue of the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019)('MAR') as well as the applicable laws and regulations of the Financial Conduct Authority.

All other terms of the Programme, as set out in the Programme launch announcement on 15 May 2025, remain unchanged. Any purchase of Ordinary Shares by the Company will be notified through an RIS announcement in accordance with the UK Listing Rules.

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Peter Atkinson Chief Executive

Ivor Gray Finance Director

 

Spreng Thomson

Callum Spreng

Mob: 07803 970103

 

Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73

 

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange (LSE: MACF) since 1973 with over 75 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,200 people at 42 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with over 2,000 suppliers, Macfarlane Group distributes and manufactures to a wide range of sectors, including: logistics; electronics; defence; medical; automotive; aerospace; retail e-commerce; and food.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDULDBDGLD
Date   Source Headline
6th Jul 20267:00 amRNSTransaction in Own Shares
30th Jun 20267:00 amRNSDefined benefit pension scheme buy-in
29th Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20263:30 pmRNSExtension of Share Buyback Programme
12th May 20263:28 pmRNSResult of AGM
12th May 20267:00 amRNSAGM Trading Update
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20262:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSNotice of AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:40 amRNSDirector/PDMR Shareholdings
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202612:12 pmRNSDirector/PDMR Shareholdings
2nd Mar 20268:26 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSAnnual Results 2025
23rd Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:02 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:01 amRNSNotice of Results & Investor Presentation
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTrading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20258:27 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.